-
张博，梁玉宁，鲍友利，朱利，孙鑫，吴鸿飞（安徽中医药大学药学院，中药研究与开发安徽省重点实验室）.基于网络药理学和实验验证探究经典药对“瓜蒌-薤白”治疗痰瘀互结心血管疾病的作用机制[J].药学学报,2023,第6期
-
Zhu Lingling，Yu Xianzhe，Cao Ting，Deng Hanyu，Tang Xiaojun，Lin Qing，Zhou Qinghua.Immune cell membrane-based biomimetic nanomedicine for treating cancer metastasis[J].药学学报,2023,第6期
-
Chen Chao，Zhong Wu，Du Shiyu，Li Yayao，Zeng Yunfei，Liu Kunguo，Yang Jingjing，Guan Xiaoxiang，Han Xin.Intelligent nanotherapeutic strategies for the delivery of CRISPR system[J].药学学报,2023,第6期
-
Ren Yuehong，Wu Wei，Zhang Xingwang.The feasibility of oral targeted drug delivery:Gut immune to particulates?[J].药学学报,2023,第6期
-
Wu Jialu，Wan Yue，Wu Zhenxing，Zhang Shengyu，Cao Dongsheng，Hsieh Changyu，Hou Tingjun.MF-SuP-pK_a:Multi-fidelity modeling with subgraph pooling mechanism for pK_a prediction[J].药学学报,2023,第6期
-
Du Guangsheng，Qin Ming，Sun Xun.Recent progress in application of nanovaccines for enhancing mucosal immune responses[J].药学学报,2023,第6期
-
Yu Qian，Li Chang，Niu Qinghui，Wang Jigang，Che Zhaodi，Lei Ke，Ren He，Ma Boyi，Ren Yixing，Luo Pingping，Fan Zhuming，Zhang Huan，Liu Zhaohui，Tipoe George L，Xiao Jia.Hepatic COX1 loss leads to impaired autophagic flux and exacerbates nonalcoholic steatohepatitis[J].药学学报,2023,第6期
-
Jin Xin，Qiu Tingting，Li Li，Yu Rilei，Chen Xiguang，Li Changgui，Proud Christopher G，Jiang Tao.Pathophysiology of obesity and its associated diseases[J].药学学报,2023,第6期
-
Ye Jianping.Commentary:Inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetes[J].药学学报,2023,第6期
-
Ru Nan，Sun Wanyang，Wang Huajun，Wu Yanping，Zheng Xiaofei，He Rongrong.Commentary:A nearly forgotten class of antiinflammatory lipid molecules in central nervous system[J].药学学报,2023,第6期
-
Zhu Qi，Song Juxian，Chen Jiayue，Yuan Zhenwei，Liu Liangfeng，Xie Liming，Liao Qiwen，Ye Richard D，Chen Xiu，Yan Yepiao，Tan Jieqiong，Tan Chris Soon Heng，Li Min，Lu Jiahong.Corynoxine B targets at HMGB1/2 to enhance autophagy for alpha-synuclein clearance in fly and rodent models of Parkinson's disease[J].药学学报,2023,第6期
-
Li Pengyun，Jia Changkai，Fan Zhiya，Hu Xiaotong，Zhang Wenjuan，Liu Ke，Sun Shiyang，Guo Haoxin，Yang Ning，Zhu Maoxiang，Zhuang Xiaomei，Xiao Junhai，Zheng Zhibing，Li Song.Discovery of novel exceptionally potent and orally active c-MET PROTACs for the treatment of tumors with MET alterations[J].药学学报,2023,第6期
-
Kang Weirong，Liu Yuwei，Wang Weiping.Light-responsive nanomedicine for cancer immunotherapy[J].药学学报,2023,第6期
-
Gao Shenghua，Song Letian，Cheng Yusen，Zhao Fabao，Kang Dongwei，Song Shu，Yang Mianling，Ye Bing，Zhao Wei，Tang Yajie，Clercq Erik De，Pannecouque Christophe，Zhan Peng，Liu Xinyong.Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles[J].药学学报,2023,第6期
-
Shi Gaona，Zhou Yu，Liu Wenshuai，Chen Chengjuan，Wei Yazi，Yan Xinlong，Wu Lei，Wang Weiwei，Sun Lan，Zhang Tiantai.Bone-derived MSCs encapsulated in alginate hydrogel prevent collagen-induced arthritis in mice through the activation of adenosine A2A/2B receptors in tolerogenic dendritic cells[J].药学学报,2023,第6期
-
Wang Yanping，Gao Yanfeng，Pan Yongchun，Zhou Dongtao，Liu Yuta，Yin Yi，Yang Jingjing，Wang Yuzhen，Song Yujun.Emerging trends in organ-on-a-chip systems for drug screening[J].药学学报,2023,第6期
-
Zhang Yanqiong，Li Xin，Shi Yulong，Chen Tong，Xu Zhijian，Wang Ping，Yu Meng，Chen Wenjia，Li Bing，Jing Zhiwei，Jiang Hong，Fu Lu，Gao Wenjing，Jiang Yanhua，Du Xia，Gong Zipeng，Zhu Weiliang，Yang Hongjun，Xu Haiyu.ETCM v2.0:An update with comprehensive resource and rich annotations for traditional Chinese medicine[J].药学学报,2023,第6期
-
Luan Jiayi，Li Ruotao，Xu Weiguo，Sun Huiying，Li Qiqi，Wang Di，Dong Shujun，Ding Jianxun.Functional biomaterials for comprehensive periodontitis therapy[J].药学学报,2023,第6期
-
Xie Yaochen，Zhou Qian，He Qiaojun，Wang Xiaoyi，Wang Jincheng.Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition[J].药学学报,2023,第6期
-
Peng Kezheng，Zeng Chenye，Gao Yuqi，Liu Binliang，Li Liyuan，Xu Kang，Yin Yuemiao，Qiu Ying，Zhang Mingkui，Ma Fei，Wang Zhao.Overexpressed SIRT6 ameliorates doxorubicininduced cardiotoxicity and potentiates the therapeutic efficacy through metabolic remodeling[J].药学学报,2023,第6期
-
周慧宇，朱梅，王玉成（中国医学科学院，北京协和医学院医药生物技术研究所）.ProTide技术研究进展及其在抗病毒药物研究领域中的应用[J].药学学报,2023,第6期
-
李惠兰1，杨尊华2，应宇琦2，房元英1（江西中医药大学中药固体制剂制造技术国家工程研究中心；江西中医药大学药学院）.靶向特定氨基酸的活性探针研究进展[J].药学学报,2023,第6期
-
王晓彤，张程璐，薄茹雪，周诗绮，陈乃宏，苑玉和（中国医学科学院药物研究所，天然药物活性物质与功能国家重点实验室）.建立大麻素1型受体激动剂的细胞筛选模型[J].药学学报,2023,第6期
-
Chen Jing，Ji Peng，Gnawali Giri，Chang Mengyang，Gao Feng，Xu Hang，Wang Wei.Building bioorthogonal click-release capable artificial receptors on cancer cell surface for imaging, drug targeting and delivery[J].药学学报,2023,第6期
-
Li Bingbing，Teng Chao，Yu Huiling，Jiang Xiaohong，Xing Xuyang，Jiang Qi，Lin Chenshi，Zhao Zongmin，Zhang Ruifeng，He Wei.Alleviating experimental pulmonary hypertension via co-delivering FoxO1 stimulus and apoptosis activator to hyperproliferating pulmonary arteries[J].药学学报,2023,第6期
-
Zhang Wenxin，Pan Xiaohui，Xu Yanjun，Guo Hongjie，Zheng Mingming，Chen Xi，Wu Honghai，Luan Fengming，He Qiaojun，Ding Ling，Yang Bo.Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA[J].药学学报,2023,第6期
-
Shi Chen，Zhang Cong，Fu Zhiwen，Liu Jinmei，Zhou Yuanfeng，Cheng Bao，Wang Cong，Li Shijun，Zhang Yu.Antitumor activity of aumolertinib, a thirdgeneration EGFR tyrosine kinase inhibitor, in non-small-cell lung cancer harboring uncommon EGFR mutations[J].药学学报,2023,第6期
-
Wang Bingwei，Ma Yan，Li Sheng，Yao Hang，Gu Mingna，Liu Ying，Xue You，Ding Jianhua，Ma Chunmei，Yang Shuo，Hu Gang.GSDMD in peripheral myeloid cells regulates microglial immune training and neuroinflammation in Parkinson's disease[J].药学学报,2023,第6期
-
Liang Tao，Wang Fengli，Elhassan Reham M，Cheng Yongmei，Tang Xiaolei，Chen Wengang，Fang Hao，Hou Xuben.Targeting histone deacetylases for cancer therapy:Trends and challenges[J].药学学报,2023,第6期
-
Wang Xiaomin，Xu Jun，Sun Yiming，Cao Siyuwei，Zeng Hanlin，Jin Nan，Shou Matthew，Tang Shuai，Chen Yi，Huang Min.Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer[J].药学学报,2023,第6期
|